SMS Pharmaceuticals Q2 FY27 Results: PAT Surges 57% YoY to ₹39.85 Crore
SMS Pharmaceuticals Ltd · Others (Uncategorized) · 04 Nov 2026, 7:09 pm
SMS Pharmaceuticals Q2 FY27 Results: PAT Surges 57% YoY to ₹39.85 Crore SMS Pharmaceuticals reported a consolidated revenue from operations of ₹316.09 crore for Q2 ended 30th Sep'26, rising 30.38% YoY from ₹242.43 crore and 52.73% QoQ. Consolidated net profit grew 57.44% YoY to ₹39.85 crore compared to ₹25.31 crore in Q2 ended 30th Sep'25, with basic EPS increasing to ₹4.26 from ₹2.84 YoY. Additionally, the board approved the resignation of Company Secretary Thirumalesh Tumma effective 4th Nov'26 and appointed Manohar Mollama as the new Company Secretary & Compliance Officer effective 5th Nov'26.
Original exchange filing (PDF)
More announcements from SMS Pharmaceuticals Ltd
- Earnings Call Transcript · 10 Nov 2026
- Investors Meet Audio Recording · 05 Nov 2026
- Press release on Financial Results · 05 Nov 2026
- Investor Presentation for quarter and half year ended September 30, 2026 · 04 Nov 2026
- SMS Pharmaceuticals Limited has informed the Exchange about General Updates · 04 Nov 2026
- Change in Management_Company Secretary · 04 Nov 2026
- SMS Pharmaceuticals Limited has informed the Exchange about Change in Company Secretary/Compliance Officer · 04 Nov 2026
- Outcome of Board Meeting and Financial Results · 04 Nov 2026
